Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-24

Clinical Trial Update: Airway Clearance Study [Phase 4]

View source ↗

Summary

Phase 4 Airway Clearance Study sponsored by AstraZeneca in chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED